clinical trials

FDA's Robert Califf calls on insurers to help providers participate in critical clinical drug trials
FDA's Robert Califf calls on insurers to help providers participate in critical clinical drug trials
Fierce Healthcare
Robert Califf
FDA
insurers
clinical trials
Flag link:
Karuna’s schizophrenia drug succeeds in a second late-stage trial
Karuna’s schizophrenia drug succeeds in a second late-stage trial
BioPharma Dive
Karuna
clinical trials
schizophrenia
KarXT
Flag link:
Takeda, chasing Bristol Myers, unveils awaited TYK2 drug data
Takeda, chasing Bristol Myers, unveils awaited TYK2 drug data
BioPharma Dive
Takeda
Bristol Myers Squibb
clinical trials
TAK-279
plaque psoriasis
Flag link:
Gossamer pauses enrollment of lymphoma med, citing risk-benefit profile
Gossamer pauses enrollment of lymphoma med, citing risk-benefit profile
Fierce Biotech
Gossamer Bio
clinical trials
GB5121
lymphoma
Flag link:
Cash-strapped Acer sees menopause drug flunk phase 2 trial
Cash-strapped Acer sees menopause drug flunk phase 2 trial
Fierce Biotech
Acer Therapeutics
clinical trials
hot flashes
menopause
osanetant
Flag link:
Pfizer and Astellas report positive data from prostate cancer therapy trial
Pfizer and Astellas report positive data from prostate cancer therapy trial
Clinical Trials Arena
Pfizer
Astellas
prostate cancer
clinical trials
Enzalutamide
leuprolide
Flag link:
Merck's TIGIT fails in phase 2 Keytruda combo, notching another loss for the class
Merck's TIGIT fails in phase 2 Keytruda combo, notching another loss for the class
Fierce Biotech
Merck
Keytruda
clinical trials
vibostolimab
non-small cell lung cancer
metastatic non-small cell lung cancer
Flag link:
Duchenne muscular dystrophy: major trials and events to watch in 2023
Duchenne muscular dystrophy: major trials and events to watch in 2023
Clinical Trials Arena
DMD
Duchenne Muscular Dystrophy
clinical trials
gene therapy
FDA
Sarepta Therapeutics
SRP-9001
FibroGen
pamrevlumab
Capricor
CAP-1002
Santhera
ReveraGen
vamorolone
Flag link:
Bellicum Weighs Options After Serious Safety Concerns Halt Only Trials
Bellicum Weighs Options After Serious Safety Concerns Halt Only Trials
BioSpace
Bellicum
clinical trials
GoCAR-T
Flag link:
Bristol Myers meets some diversity goals early, while missing others
Bristol Myers meets some diversity goals early, while missing others
Endpoints
Bristol Myers Squibb
diversity
clinical trials
clinical trial diversity
Flag link:
Veru Moves Forward with Late-Stage COVID Study Despite FDA Roadblock
Veru Moves Forward with Late-Stage COVID Study Despite FDA Roadblock
BioSpace
Veru
COVID-19
sabizabulin
clinical trials
Flag link:
Keytruda Unlocked: How Should Merck Proceed with Trials?
Keytruda Unlocked: How Should Merck Proceed with Trials?
BioSpace
Keytruda
Merck
cancer
clinical trials
Flag link:
Acesion, targeting first new approach to AF in decades, hits primary endpoint in midphase trial
Acesion, targeting first new approach to AF in decades, hits primary endpoint in midphase trial
Fierce Biotech
Acesion Pharma
atrial fibrillation
clinical trials
AP30663
Flag link:
FDA pauses Mersana’s clinical trial after patient dies
FDA pauses Mersana’s clinical trial after patient dies
Endpoints
Mersana
clinical trials
FDA
patient death
cancer
XMT-2056
antibody-drug conjugate
Flag link:
Merck reports positive data from malignant pleural mesothelioma trial
Merck reports positive data from malignant pleural mesothelioma trial
Clinical Trials Arena
Merck
Canadian Cancer Trials Group
clinical trials
Keytruda
mesothelioma
Flag link:
In PD-1 rivalry, Merck's Keytruda catches up with Opdivo in rare lung cancer type
In PD-1 rivalry, Merck's Keytruda catches up with Opdivo in rare lung cancer type
Fierce Pharma
Merck
Keytruda
Opdivo
Bristol Myers Squibb
pleural mseothelioma
mesothelioma
clinical trials
Flag link:
Astellas Xospata comes up short again in bid to expand leukemia use
Astellas Xospata comes up short again in bid to expand leukemia use
Fierce Pharma
Astellas
Xospata
AML
clinical trials
Flag link:
Lilly’s Alzheimer’s struggles continue as preclinical asset fails phase III
Lilly’s Alzheimer’s struggles continue as preclinical asset fails phase III
BioSpace
Eli Lilly
Alzheimer's disease
solanezumab
clinical trials
Flag link:
Tagrisso reaches OS endpoint in PhIII EGFR-mutated lung cancer trial
Tagrisso reaches OS endpoint in PhIII EGFR-mutated lung cancer trial
Endpoints
AstraZeneca
lung cancer
clinical trials
Tagrisso
Flag link:
eConsent in clinical trials: what’s new and what’s yet to come?
eConsent in clinical trials: what’s new and what’s yet to come?
Clinical Trials Arena
eConsent
informed consent
clinical trials
Flag link:

Pages